IBDEI1ZP ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33763,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,33764,0)
 ;;=R80.3^^131^1676^84
 ;;^UTILITY(U,$J,358.3,33764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33764,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,33764,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,33764,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,33765,0)
 ;;=R80.9^^131^1676^89
 ;;^UTILITY(U,$J,358.3,33765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33765,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,33765,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,33765,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,33766,0)
 ;;=Z87.442^^131^1676^77
 ;;^UTILITY(U,$J,358.3,33766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33766,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,33766,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,33766,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,33767,0)
 ;;=N18.1^^131^1676^13
 ;;^UTILITY(U,$J,358.3,33767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33767,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,33767,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,33767,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,33768,0)
 ;;=N18.2^^131^1676^14
 ;;^UTILITY(U,$J,358.3,33768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33768,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,33768,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,33768,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,33769,0)
 ;;=N18.3^^131^1676^15
 ;;^UTILITY(U,$J,358.3,33769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33769,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,33769,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,33769,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,33770,0)
 ;;=N18.4^^131^1676^16
 ;;^UTILITY(U,$J,358.3,33770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33770,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,33770,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,33770,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,33771,0)
 ;;=N18.5^^131^1676^17
 ;;^UTILITY(U,$J,358.3,33771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33771,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,33771,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,33771,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,33772,0)
 ;;=Q61.3^^131^1676^80
 ;;^UTILITY(U,$J,358.3,33772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33772,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,33772,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,33772,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,33773,0)
 ;;=N20.1^^131^1676^9
 ;;^UTILITY(U,$J,358.3,33773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33773,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,33773,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,33773,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,33774,0)
 ;;=N18.9^^131^1676^18
 ;;^UTILITY(U,$J,358.3,33774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33774,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,33774,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,33774,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,33775,0)
 ;;=N18.6^^131^1676^28
 ;;^UTILITY(U,$J,358.3,33775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33775,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,33775,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,33775,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,33776,0)
 ;;=N52.9^^131^1676^44
 ;;^UTILITY(U,$J,358.3,33776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33776,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,33776,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,33776,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,33777,0)
 ;;=N32.81^^131^1676^75
